SOL vs. HIVE

Last updated Jun 4, 2026

SOL (ReneSola Ltd) and HIVE (HIVE Blockchain Technologies Ltd) are both stocks. SOL operates in Solar (Technology), while HIVE operates in Capital Markets (Financial Services).

Performance

SOL vs. HIVE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ReneSola Ltd (SOL) and HIVE Blockchain Technologies Ltd (HIVE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

SOL

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

HIVE

• 1D: -3.52%
• 1M: 68.46%
• YTD: 69.77%
• 6M: 33.54%
• 1Y: 132.98%
• 3Y*: 10.46%
• 5Y*: -18.86%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

SOL vs. HIVE - Yearly Performance Comparison

	2026 (YTD)
SOL ReneSola Ltd	0.00%
HIVE HIVE Blockchain Technologies Ltd	87.98%

Fundamentals

EPS SOL : -$0.10 HIVE : -$0.33
PS Ratio SOL : 1.40 HIVE : 3.75
Total Revenue (TTM) SOL : $71.23M HIVE : $257.14M
Gross Profit (TTM) SOL : $24.18M HIVE : $58.57M
EBITDA (TTM) SOL : -$20.64M HIVE : $87.81M

Return for Risk

SOL vs. HIVE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HIVE

HIVE Risk / Return Rank: 74
HIVE Sharpe Ratio Rank: 79
HIVE Sortino Ratio Rank: 80
HIVE Omega Ratio Rank: 75
HIVE Calmar Ratio Rank: 72
HIVE Martin Ratio Rank: 65

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SOL vs. HIVE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ReneSola Ltd (SOL) and HIVE Blockchain Technologies Ltd (HIVE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	SOL	HIVE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.41	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.20	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.11	—

Drawdowns

SOL vs. HIVE - Drawdown Comparison

The maximum SOL drawdown since its inception was 0.00%, smaller than the maximum HIVE drawdown of -97.73%. Use the drawdown chart below to compare losses from any high point for SOL and HIVE.

Drawdown Indicators

	SOL	HIVE	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-97.73%	+97.73%
Max Drawdown (1Y) Largest decline over 1 year	—	-74.86%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-80.27%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-94.61%	—
Current Drawdown Current decline from peak	0.00%	-83.67%	+83.67%
Average Drawdown Average peak-to-trough decline	0.00%	-78.58%	+78.58%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	46.13%	—

Volatility

Volatility by Period

	SOL	HIVE	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	35.94%	—
Volatility (6M) Calculated over the trailing 6-month period	—	64.68%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	94.75%	-94.75%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	92.84%	-92.84%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	109.18%	-109.18%

Dividends

SOL vs. HIVE - Dividend Comparison

Neither SOL nor HIVE has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

SOL vs. HIVE - Profitability Comparison

The chart below illustrates the profitability comparison between ReneSola Ltd and HIVE Blockchain Technologies Ltd over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

SOL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ReneSola Ltd reported a gross profit of 9.52M and revenue of 15.64M. Therefore, the gross margin over that period was 60.8%.

HIVE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, HIVE Blockchain Technologies Ltd reported a gross profit of 32.14M and revenue of 93.11M. Therefore, the gross margin over that period was 34.5%.

SOL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ReneSola Ltd reported an operating income of 6.82M and revenue of 15.64M, resulting in an operating margin of 43.6%.

HIVE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, HIVE Blockchain Technologies Ltd reported an operating income of 16.70M and revenue of 93.11M, resulting in an operating margin of 17.9%.

SOL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ReneSola Ltd reported a net income of 3.47M and revenue of 15.64M, resulting in a net margin of 22.2%.

HIVE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, HIVE Blockchain Technologies Ltd reported a net income of -91.33M and revenue of 93.11M, resulting in a net margin of -98.1%.